Brief: Vaxart Announces Collaborative Funding From Leading Foundation To Study Its Norovirus Vaccine Candidate In Breastfeeding Mothers
01/12/2022 13:12
Dec 1 (Reuters) - Vaxart Inc VXRT.O :
* VAXART ANNOUNCES COLLABORATIVE FUNDING FROM LEADING
FOUNDATION
TO STUDY ITS NOROVIRUS VACCINE CANDIDATE IN BREASTFEEDING
MOTHERS
* VAXART INC - FUNDING AND SUPPORT PROVIDED BY BILL &
MELINDA
GATES FOUNDATION
Source text for Eikon: ID:nGNX60SfpC
Further company coverage: VXRT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts